CD4 and COVID-19: Early induction [26] and antigenic diversity [6] of the SARS-CoV-2-specific T-cell responses is associated with mild COVID-19 and cross reactivity with CD4+ T cell responses to other human coronaviruses are associated with mild infection [13–16].